Similar articles

• Hydroxyurea increases fetal hemoglobin production in sickle cell anemia.

  Platt OS, Orkin SH, Dover G, Beardsley GP, Miller B, Nathan DG. Platt OS, et al. Trans Assoc Am Physicians. 1984;97:268-74. Trans Assoc Am Physicians. 1984. PMID: 6085528 No abstract available.
• Increasing fetal hemoglobin in sickle cell disease: comparisons of 5-azacytidine (subcutaneous or oral) with hydroxyurea.

  Dover GJ, Charache S, Boyer SH. Dover GJ, et al. Trans Assoc Am Physicians. 1984;97:140-5. Trans Assoc Am Physicians. 1984. PMID: 6085527 No abstract available.
• Sickle cell anemia: targeting the role of fetal hemoglobin in therapy.

  Coleman E, Inusa B. Coleman E, et al. Clin Pediatr (Phila). 2007 Jun;46(5):386-91. doi: 10.1177/0009922806297751. Clin Pediatr (Phila). 2007. PMID: 17556734 Review.
• Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.

  Pearson HA. Pearson HA. Adv Pediatr. 1996;43:309-34. Adv Pediatr. 1996. PMID: 8794181 Review. No abstract available.
• Induction of fetal hemoglobin in sickle cell patients by hydroxyurea: the N.I.H. experience.

  Rodgers GP, Dover GJ, Noguchi CT, Schechter AN, Nienhuis AW. Rodgers GP, et al. Prog Clin Biol Res. 1989;316B:281-93. Prog Clin Biol Res. 1989. PMID: 2482498 No abstract available.